Substantial equivalence is the key to getting your Class II medical device cleared for sale by the US Food and Drug Administration. The bulk of the documentation in your regulatory submission, called a 510(k), must demonstrate your device is "substantially equivalent" to another medical device already cleared for sale by the FDA.
So what does it mean to be substantially equivalent? In this white paper, we answer your biggest questions about substantial equivalence and its role in the FDA regulatory process, including:
Learn all this and much more in this 7-page white paper.
Audrey Swearingen, RAC (US): Audrey Swearingen is Director of Regulatory Affairs at Emergo's Austin, Texas headquarters. With over 20 years of experience in regulatory affairs, Audrey's areas of expertise include US FDA medical device registration, as well as European and Canadian device registration.
Usability testing is critical for establishing that a medical device or IVD can be used safely and effectively, and it can also capture feelings fr
read moreDesigners from Emergo by UL’s Human Factors Research & Design (HFR&D) team share tips and insights about the importance of hardware user in
read more